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Chronic pancreatitis is a progressive inflammatory disease resulting from repeated episodes of acute 
pancreatitis that impair exocrine function and eventually produce endocrine insufficiency. Some 
causes of chronic pancreatitis appear to be associated with alterations in the serine–protease inhibitor, 
Kazal type 1 (SPINK1), cationic trypsinogen (PRSS1), and cystic fibrosis–transmembrane conductance 
regulator (CFTR ) genes, or with structural disorders in the pancreaticobiliary ductal system, such as 
pancreatic divisum or anomalous pancreaticobiliary ductal union (APBDU). However, it is unusual to 
observe both genetic alteration and structural anomaly. Here, we report 2 cases with both APBDU and 
a mutation in the SPINK1 genes, and we discuss the implications of these findings in clinical practice.
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Introduction
Chronic pancreatitis (CP) is a progressive inflammatory disease, initiated by repeated 
episodes of acute pancreatitis, that results in impairment of exocrine and eventually 
endocrine insufficiency1,2). In spite of careful analysis, it can be difficult to determine the 
causes of the disease and sometimes a genetic study is useful. Some researchers observe 
that serine protease inhibitor, Kazal type 1 (SPINK1), cationic trypsinogen (PRSS1) or 
cystic fibrosis transmembrane conductance regulator (CFTR) genes are pancreatitis sus­
ceptibility genes and individuals who have these genes rapidly progress to CP1,3­5). 
Anomalous pancreaticobiliary ductal union (APBDU) is a disorder in which the junctional 
union between the common bile duct (CBD) and the pancreatic duct outside the duodenal 
wall has an abnormal position beyond the influence of the sphincter of Oddi6). In this 
pathologic condition, reflux of pancreatic juice into the biliary tract system occurs 
because of the lack of Oddi’s sphincter function7). It is frequently associated with various 
pancreaticobiliary diseases, including choledochal cyst, bile duct cancer, gallbladder 
cancer, gallbladder adenomyomatosis, pancreatitis, and pancreas divisum6,7). Pancreas 
divisum is also a well known cause of acute recurrent pancreatitis8). 
We report two cases with APBDU with CP. After surgical or endoscopic sphincterotomy 
(EST) treatment for APBDU, both patients had pancreatitis relapses. And eventually both 
patients revealed to have a genetic mutation of SPINK1 gene. We discuss the implications 
of the findings with the controversial issues of anatomical defects of the pancreas such as 
APBDU with genetic mutation in the context of CP.
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Case report
1. Case 1
A 2 year 8 month old girl presented with intermittent severe 
right upper abdominal pain for six days. In spite of fasting and 
conservative care, her pain remained. Choledochal cyst was 
found in ultrasonography. She was referred to our hospital 
for further evaluation and management of choledochal cyst. 
Magnetic resonance cholangiopancreatography (MRCP) showed a 
choledochal cyst (type IVa) with APBDU (P­C type) and bile sludge 
in the CBD and common channel (Fig. 1). Hepaticojejunostomy 
with jejunostomy and excision of choledochal cyst was performed. 
At the routine checkup two years later, blood test results of 
serum amylase and lipase levels were 210 U/L and 125 U/L. 
MRCP was done again which showed focal dilatation of the 
upstream pancreatic duct and pancreatic duct stone. Endoscopic 
retrograde cholangiopancreatography (ERCP) was performed and 
the pancreatic duct stone was removed (Fig. 2). To evaluate the 
etiology of CP, screening tests including infection and autoimmune 
disorders were performed and a genetic study was done. Genetic 
testing revealed mutations in CP: p.N34S mutation in the SPINK1 
gene (Fig. 3A).
2. Case 2
A 4 year 6 month old girl with five days of periumbilical 
abdo minal pain and vomiting visited a local clinic. An initial 
workup which was remarkable for elevated amylase and lipase 
(1,135 U/L and 2,950 U/L, respectively) confirmed the diagnosis 
of acute pancreatitis. She was brought to Severance Children’s 
Hospital for further evaluation of pancreatitis. After conservative 
care for fifteen days, blood test results showed normal levels of 
amylase and lipase. After five days of normalization, abdominal 
pain recurred. Amylase and lipase were re­elevated (251 U/L 
and 1,259 U/L, respectively). The abdominal pain prompted a 
comprehensive evaluation for CP. MRCP demonstrated pancreatitis 
with pancreas swelling and pancreatic duct dilatation. Ectopic 
insertion of CBD and ventral pancreatic duct and pancreatic 
divisum was seen (Fig. 4). ERCP was performed and EST of major 
papilla and minor papilla was done instead of operation. ERCP 
Fig. 1. Magnetic resonance cholangiopancreatography revealed a chole­
dochal cyst (type IVa) with anomalous pancreaticobiliary ductal union (P­C 
type) and bile sludge in the common bile duct and common channel.
Fig. 2. Endoscopic retrograde cholangiopancreatography showed focal dilatation of the upstream 
pancreatic duct and a pancreatic duct stone (A). Pancreatic duct after stone removal (B).
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demonstrated incomplete pancreas divisum and APBDU. The 
major papilla of the duodenum was not remarkable. Selective 
deep cannulation of the bile duct was done successfully and the 
sphincterotomy was performed with pull type sphincterotome. 
On the cholangiography obtained by the major papilla selective 
cannulation, the bile duct was observed to have no dilation or 
obstruction. However, the main pancreatic duct was visualized 
just 1.5 cm distal to the ampulla and joined with CBD. On the 
minor papilla, the minor pancreatic duct was communicated to 
the body and tail of the pancreas with dilation. After two months 
of EST, MRCP was done again and demonstrated a decreased 
caliber of the dorsal pancreatic duct and no remarkable changes 
of CBD, intrahepatic duct, or ventral pancreatic duct. Pancreatic 
enzymes were checked in an outpatient clinic and the enzyme 
levels presented in a wax and wane pattern. Genetic testing 
revealed SPINK1 IVS3+2T>C splicing mutations (Fig. 3B).
Discussion
The known causes of pancreatitis in children are trauma, 
drug toxicity, infection, metabolic disorders, anatomic defects, 
hereditary pancreatitis, and vascular disease9). In recent studies 
pancreatitis­associated susceptibility genes were detected3). 
PRSS1 gene cause hereditary pancreatitis, CFTR mutation are 
associated with idiopathic CP and SPNIK1 are associated with 
CP1,3,4,5). SPINK1 mutations are more common than PRSS1 muta­
tions in patients with acute recurrent pancreatitis or CP10). On 
SPINK1 mutation, p.N34S and IVS3+2T>C mutations are most 
frequently observed10­12). 
There are reports of pancreas divisum associated with CP with 
SPINK1 mutation10). CP associated with APBDU, combined with 
SPINK1 mutation has not previously reported. In this report, 
one case had a choledochal cyst (type IVa) with APBDU and had 
surgical treatment. The other case has an incomplete pancreas 
divisum with APBDU and had an endoscopic therapeutic interven­
tion. After the procedure, even though the anatomical correction 
was done, both patients had recurrent pancreatitis and were 
diagnosed with CP. 
If functional and structural abnormalities of the pancreas 
surface are coexisted, the final diagnosis of chronic recurrent 
pancreatitis is often made only several years after the first 
occurrence of pancreatitis with laboratory studies and imaging13). 
Until now, genetic testing in CP patients has not been part of any 
standard diagnostic procedure. Criteria for PRSS1 and SPINK1 
mutation testing are controversial but include: recurrent acute 
pancreatitis with a family history of CP, CP without another 
etiology with or without a positive family history after ruling 
Fig. 3. Partial DNA sequence of SPINK1, located on 5q32, with the heterozygote c.104A>G (p.Asn34Ser) mutation 
in exon 3 of SPINK1. The 3 nucleotides for coding the amino acid are marked in the box (A). The c.194+2T>C, 
intron 3­splicing donor­site mutation is marked in the open circle with the exon­intron boundary signs (B). Upper 
panel: normal electrogram; lower panel: patient’s electrogram. Sites of heterozygote mutation are indicated with 
arrows. R, heterozygote of nucleotides A and G; Y, nucleotides T and C.
Fig. 4. Magnetic resonance cholangiopancreatography revealed pancreatic 
divisum and swelling of pancreas with ductal dilatation. The dorsal main 
pancreatic duct connect to the minor papilla and the ventral pancreatic 
duct joined the common bile duct (CBD) and drained into the major 
papilla (ectopic insertion of CBD and ventral pancreatic duct). The major 
papilla is seen at the junction of the second and third parts of the duodenum.
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out other causes for pancreatitis, or unexplained pancreatitis in 
children14). In this cases, PRSS1 and SPINK1 mutation testing 
was done because CP occurred after anatomical correction, and 
both patient had SPINK1 mutation.
SPINK1  is a potent protease inhibitor which prevents 
premature intrapancreatic activation of trypsin and pancreatic 
autodigestion and act as a protector. Studies described strong 
associations of SPINK1 mutation and different forms of pan­
creatitis13,15), but SPINK1 mutation alone is incapable of initiating 
pancreatitis and cause CP10,15). This mutation acts as a disease­
modifier or plays a role within polygenic or multifactorial models 
1,12,15). Mutations in the SPINK1 gene have been reported to lower 
the threshold for pancreatitis in the presence of other genetic or 
environmental factors and acts as a disease­modifier4,10,15). 
An anatomic defect may be an incidental finding or a contri­
buting factor in pancreatitis. Deliberating the possibility of 
combined diseases is important due to plausible relations of 
acute pancreatitis, choledochal cyst and gall bladder cancer in 
APBDU patients. Especially those combined with pancreatitis, 
complications and its association with APBDU seems to lead to 
more risks. In patients with APBDU, surgical correction of such a 
defect remains controversial but it may alleviate symptoms and 
prevent further damage to the pancreas from recurrent attacks of 
pancreatitis9).
Therefore, studies for gene mutation as a disease­modifier are 
needed if pancreatitis does occur secondarily to an anatomic 
defect, even if anatomically correction of the pancreatic ductal 
system was done. 
Conflict of interest
No potential conflict of interest relevant to this article was 
reported.
References
 1.  Schneider A. Serine protease inhibitor Kazal type 1 mutations and 
pancreatitis. Clin Lab Med 2005;25:61­78.
 2.  Ota Y, Masamune A, Inui K, Kume K, Shimosegawa T, Kikuyama 
M. Phenotypic variability of the homozygous IVS3+2T>C muta­
tion in the serine protease inhibitor Kazal type 1 (SPINK1) gene in 
patients with chronic pancreatitis. Tohoku J Exp Med 2010;221: 
197­201.
 3.  Morinville V, Whitcomb DC. Recurrent acute and chronic pancreatitis: 
complex disorders with a genetic basis. Gastroenterol Hepatol 2005; 
1:195­205.
 4.  Schneider A, Barmada MM, Slivka A, Martin JA, Whitcomb DC. 
Clinical characterization of patients with idiopathic chronic pan ­
creatitis and SPINK1 mutations. Scand J Gastroenterol 2004;39: 
903­4.
 5.  Liddle RA. Pathophysiology of SPINK mutations in pancreatic 
development and disease. Endocrinol Metab Clin North Am 2006; 
35:345­56.
 6.  Katsinelos P, Dimiropoulos S, Katsiba D, Galanis I, Pilpilidis I, Tsolkas 
P, et al. Acute recurrent pancreatitis associated with anomalous 
pancreaticobiliary ductal union and choledochal cyst of mixed 
type I plus II. Surg Endosc 2003;17:162.
 7.  Shimotake T, Aoi S, Tomiyama H, Iwai N. DPC­4 (Smad­4) and 
K­ras gene mutations in biliary tract epithelium in children with 
anomalous pancreaticobiliary ductal union. J Pediatr Surg 2003;38: 
694­7.
 8.  Park JB, Seo JH, Park JY, Park SW, Song SY, Chung JB, et al. Endo­
scopic treatment of a pediatric patient with acute pancreatitis 
caused by anomalous union of pancreaticobiliary duct combined 
with incomplete pancreatic divisum. Korean J Gastroenterol 
2009;54:333­6.
 9.  Muzaffar AR, Moyer MS, Dobbins J, Cahow CE, Gryboski JD, Shneider 
BL. Pancreas divisum in a family with hereditary pancreatitis. J 
Clin Gastroenterol 1996;22:16­20.
 10.  Lee YJ, Kim KM, Choi JH, Lee BH, Kim GH, Yoo HW. High incidence 
of PRSS1 and SPINK1 mutations in Korean children with acute 
recurrent and chronic pancreatitis. J Pediatr Gastroenterol Nutr 
2011;52:478­81.
 11.  Truninger K, Witt H, Kock J, Kage A, Seifert B, Ammann RW, et 
al. Mutations of the serine protease inhibitor, Kazal type 1 gene, in 
patients with idiopathic chronic pancreatitis. Am J Gastroenterol 
2002;97:1133­7.
 12.  Drenth JP, te Morsche R, Jansen JB. Mutations in serine protease 
inhibitor Kazal type 1 are strongly associated with chronic pan­
creatitis. Gut 2002;50:687­92.
 13.  Derikx MH, Drenth JP. Genetic factors in chronic pancreatitis; im­
plications for diagnosis, management and prognosis. Best Pract Res 
Clin Gastroenterol 2010;24:251­70.
 14.  Rosendahl J, Bodeker H, Mossner J, Teich N. Hereditary chronic 
pancreatitis. Orphanet J Rare Dis 2007;2:1.
 15.  Oh HC, Lee TY, Kwon S, Lee SS, Seo DW, Lee SK, et al. SPINK1 N34S 
mutation as a possible cause of chronic pancreatitis in a patient 
with familial background. Korean J Gastroenterol 2007;49:384­9.
